Literature DB >> 33694069

Age of diagnosis in familial Barrett's associated neoplasia.

Amitabh Chak1,2,3, Andrew E Blum4,5,6, Benita K Glamour1, Omar Alaber2, Gino Cioffi7, Apoorva K Chandar2, Jill Barnholtz-Sloan7, Wendy Brock2, Gary W Falk8, Marcia I Canto9, Jean S Wang10, Prasad G Iyer11, Nicholas J Shaheen12, William M Grady13,14, Julian A Abrams15, Prashanthi N Thota16.   

Abstract

The identification of hereditary cancer genes for esophageal adenocarcinoma (EAC) and its precursor, Barrett's esophagus (BE), may prove critical for the development of novel prevention and treatment strategies. Specifically, efforts for detecting BE and EAC susceptibility genes have focused on families with three or more affected members, since these individuals have an earlier age onset compared to non-familial individuals. Given that the use of BE may overestimate the likelihood of disease heritability, we evaluated the age of diagnosis in kindreds with a restricted definition including only confirmed high-grade dysplasia (HGD) or EAC. The Familial Barrett's Esophagus Consortium database was used to identify individuals with HGD and EAC. These individuals were subsequently split into three kindred groups: non-familial-a single affected family member, duplex-two affected family members, and multiplex-three or more affected family members. Age of cancer diagnosis and other risk factors were compared between individuals in these groups. The study included 441 non-familial, 46 duplex, and 13 multiplex individuals. There was a statistically significant difference for age of diagnosis for individuals in the multiplex families compared to the non-familial and duplex families (56.0 versus 64.3, 63.5; p = 0.049). There was no significant difference between demographic factors and other cancer risk factors between family types. The results of this study support a genetic basis for familial Barrett's associated neoplasia and evaluation of the genetic susceptibility to this disease should continue to focus on families with multiple (three or more) affected members.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Barrett’s associated neoplasia; Barrett’s esophagus; Esophageal adenocarcinoma; Familial Barrett’s esophagus

Mesh:

Year:  2021        PMID: 33694069      PMCID: PMC9469732          DOI: 10.1007/s10689-021-00239-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.446


  10 in total

1.  Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinoma.

Authors:  C M Drovdlic; K A B Goddard; A Chak; W Brock; L Chessler; J F King; J Richter; G W Falk; D K Johnston; J L Fisher; W M Grady; S Lemeshow; C Eng
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

2.  Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction.

Authors:  Amitabh Chak; Gary Falk; William M Grady; Margaret Kinnard; Robert Elston; Sumeet Mittal; James F King; Joseph E Willis; Anokh Kondru; Wendy Brock; Jill Barnholtz-Sloan
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

3.  A segregation analysis of Barrett's esophagus and associated adenocarcinomas.

Authors:  Xiangqing Sun; Robert Elston; Jill Barnholtz-Sloan; Gary Falk; William M Grady; Margaret Kinnard; Sumeet K Mittal; Joseph E Willis; Sanford Markowitz; Wendy Brock; Amitabh Chak
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

Review 4.  Barrett's esophagus.

Authors:  Stuart J Spechler; Rhonda F Souza
Journal:  N Engl J Med       Date:  2014-08-28       Impact factor: 91.245

5.  Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.

Authors:  Amitabh Chak; Heather Ochs-Balcom; Gary Falk; William M Grady; Margaret Kinnard; Joseph E Willis; Robert Elston; Charis Eng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-09       Impact factor: 4.254

6.  Familial clustering of Barrett's esophagus and esophageal adenocarcinoma in a European cohort.

Authors:  Romy E Verbeek; Lisanne F Spittuler; Anique Peute; Martijn G H van Oijen; Fiebo J Ten Kate; Jacob R Vermeijden; Ardi Oberndorff; Jantine W P M van Baal; Peter D Siersema
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-28       Impact factor: 11.382

Review 7.  The Epidemiology of Esophageal Adenocarcinoma.

Authors:  Helen G Coleman; Shao-Hua Xie; Jesper Lagergren
Journal:  Gastroenterology       Date:  2017-08-03       Impact factor: 22.682

8.  Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus.

Authors:  Amitabh Chak; Yanwen Chen; Jaime Vengoechea; Marcia I Canto; Robert Elston; Gary W Falk; William M Grady; Kishore Guda; Margaret Kinnard; Sanford Markowitz; Sumeet Mittal; Ganapathy Prasad; Nicholas Shaheen; Joseph E Willis; Jill S Barnholtz-Sloan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-16       Impact factor: 4.254

Review 9.  Realizing the promise of cancer predisposition genes.

Authors:  Nazneen Rahman
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

10.  Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia.

Authors:  Ryan E Fecteau; Jianping Kong; Adam Kresak; Wendy Brock; Yeunjoo Song; Hisashi Fujioka; Robert Elston; Joseph E Willis; John P Lynch; Sanford D Markowitz; Kishore Guda; Amitabh Chak
Journal:  JAMA Oncol       Date:  2016-10-01       Impact factor: 31.777

  10 in total
  1 in total

Review 1.  Impact of the Tumor Microenvironment for Esophageal Tumor Development-An Opportunity for Prevention?

Authors:  Martin Borgmann; Michael Quante
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.